All
E-cigarette Users Less Likely To Quit, Decrease Use Overall Versus Traditional Cigarette Smokers
May 12th 2015E-cigarettes, championed by some as a smoking-cessation tool, may actually decrease the likelihood of quitting smoking, according to a recent population-based study of 1,000 smokers published in The American Journal of Public Health.
Two-Pronged Strategy With PARP Inhibitor Gains Traction in Breast and Ovarian Cancers
May 8th 2015A two-pronged strategy combining the PARP inhibitor Lynparza and the PI3K inhibitor BKM120 proved to be a safe and clinically beneficial regimen for women with TNBC and for patients with high-grade serous ovarian cancer.
Telephone Intervention Reduces Unplanned Hospital Visits for Patients With Blood Cancers
May 6th 2015A navigator-designed, proactive, weekly, telephone support call to help patients with blood cancers manage their symptoms between appointments was able to significantly reduce unplanned hospitalizations at a Colorado cancer center.
Sleep: An Unmet Need in Patients, Survivors, and Caregivers
May 5th 2015Insomnia, restless leg syndrome, sleep apnea, and other sleep issues often affect quality of life in cancer patients, their caregivers, and survivors. Unfortunately, sleep complaints can often be overlooked by the medical staff or not mentioned by the patient.
Chamomile and Honey are More Than Teatime Fare
May 5th 2015The concerns a family might have when a loved one develops squamous cell carcinoma of the oral cavity might seem obvious: fear that the patient will have a shorter life due to advanced disease, empathy for her pain, and a feeling of isolation in facing a rare presentation of cancer.
Clinical Trial Awareness, Enrollment Increasing
May 5th 2015While clinical trials remain a treatment option and play a significant role in furthering cancer research in treatment, symptom management and survivorship, less than 5 percent of patients participate in them, and 40 percent of patients report that they do not understand the idea of a clinical trial.
Making Progress in the Treatment of Ovarian Cancer
May 2nd 2015While surgical advances and new treatment approvals, including Lynparza and Avastin, have improved the outlook in ovarian cancer, late diagnosis and tumor resistance remain as significant barriers to major progress in treating the disease.